Alloy Therapeutics Names Krishnamurthy CSO — SkimNews
Get the Health newsletter
Daily health & science — research, biotech, public health, the studies worth knowing. Free.
- Alloy Therapeutics hired Venkat Krishnamurthy as chief scientific officer of its genetic medicines division
- Venkat Krishnamurthy previously held the same CSO title at Flashpoint Therapeutics before joining Alloy
- STAT+ publishes the appointment as part of its recurring 'Up and down the ladder' column, which invites readers to submit hires, promotions, and staffing changes for publication
Why it matters: The hire reflects Alloy Therapeutics actively recruiting an experienced scientific leader from a peer genetic-medicines startup, bolstering its CSO bench at a time of competitive hiring in the genetic medicines space.
Ask SkimNews